| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00 |
| filingDate |
2015-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b420fdb392f41a4c4e117c170558590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b2a33b573acd8d5a8160ea4a5ea15c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba1f7283fa8a4fbf6c435099650ddae5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be7416946877f40e337c6bba8fa0234e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3656f1ea3d42a65b6c106f1ac89f8b8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f53f55b8dffa0d3ab5e3a89306e7e989 |
| publicationDate |
2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016186228-A1 |
| titleOfInvention |
Method for the production of a glycosylated immunoglobulin |
| abstract |
Herein is reported a method for the production of an immunoglobulin comprising the following steps: a) providing a eukaryotic cell comprising a nucleic acid encoding the immunoglobulin, b) cultivating the eukaryotic cell in a cultivation medium wherein the amount of glucose available in the cultivation medium per time unit is kept constant and limited to less than 80% of the amount that could maximally be utilized by the cells in the cultivation medium per time unit, and c) recovering the immunoglobulin from the culture. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11377678-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11136610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874677-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9750752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11667720-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11622969-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11021728-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10231981-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10744201-B2 |
| priorityDate |
2009-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |